• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.内政部:Tenascin-C 作为一种临床相关的内源性固有免疫驱动因素。
J Histochem Cytochem. 2018 Apr;66(4):289-304. doi: 10.1369/0022155418757443. Epub 2018 Jan 31.
2
Expression and immune function of tenascin-C.肌腱蛋白-C的表达与免疫功能
Crit Rev Immunol. 2011;31(2):115-45. doi: 10.1615/critrevimmunol.v31.i2.30.
3
Tenascin-C Function in Glioma: Immunomodulation and Beyond.层粘连蛋白 C 在神经胶质瘤中的作用:免疫调节及其他。
Adv Exp Med Biol. 2020;1272:149-172. doi: 10.1007/978-3-030-48457-6_9.
4
Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers.绘制 tenascin-C 与 toll 样受体 4 的相互作用图谱揭示了一组新的内源性炎症触发物。
Nat Commun. 2017 Nov 17;8(1):1595. doi: 10.1038/s41467-017-01718-7.
5
Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.源自细胞外基质的危险相关分子模式为先天免疫提供了时间控制。
J Histochem Cytochem. 2018 Apr;66(4):213-227. doi: 10.1369/0022155417740880. Epub 2018 Jan 1.
6
Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.骨桥蛋白,一种固有组织调节剂,可治疗难治性炎症性疾病。
Pathol Int. 2011 May;61(5):265-80. doi: 10.1111/j.1440-1827.2011.02649.x. Epub 2011 Mar 8.
7
Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation.内源性危险信号 tenascin-C 的转录调控:炎症中的新型自分泌环。
J Immunol. 2010 Mar 1;184(5):2655-62. doi: 10.4049/jimmunol.0903359. Epub 2010 Jan 27.
8
Tenascin-C in fibrosis in multiple organs: Translational implications.细胞外基质蛋白 tenascin-C 在多器官纤维化中的作用:转化医学意义。
Semin Cell Dev Biol. 2022 Aug;128:130-136. doi: 10.1016/j.semcdb.2022.03.019. Epub 2022 Apr 8.
9
Alternative splicing controls cell lineage-specific responses to endogenous innate immune triggers within the extracellular matrix.选择性剪接控制细胞谱系特异性对外源细胞外基质中内源性固有免疫触发的反应。
Matrix Biol. 2020 Nov;93:95-114. doi: 10.1016/j.matbio.2020.06.003. Epub 2020 Jun 27.
10
Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155.内源性免疫控制感染:纤连蛋白 C 通过 microRNA-155 调节 TLR4 介导的炎症反应。
Cell Rep. 2012 Oct 25;2(4):914-26. doi: 10.1016/j.celrep.2012.09.005. Epub 2012 Oct 19.

引用本文的文献

1
Ex Vivo Preconditioning as a Useful Tool for Modification of the Extracellular Matrix of Multipotent Mesenchymal Stromal Cells.体外预处理作为修饰多能间充质基质细胞细胞外基质的有用工具
Int J Mol Sci. 2025 Jun 30;26(13):6301. doi: 10.3390/ijms26136301.
2
Role of High Serum Tenascin C Levels as Potential Biomarker of Persistent Inflammation in Patients with Ankylosing Spondylitis Despite Treatment with cs-DMARDS or Anti-TNF Agents.高血清腱生蛋白C水平作为强直性脊柱炎患者尽管接受传统合成改善病情抗风湿药(cs-DMARDS)或抗TNF药物治疗后仍存在持续炎症的潜在生物标志物的作用。
Diagnostics (Basel). 2025 Jun 7;15(12):1457. doi: 10.3390/diagnostics15121457.
3
Sustained tenascin-C expression drives neointimal hyperplasia and promotes aortocaval fistula failure.持续的腱生蛋白-C表达驱动新生内膜增生并促进主动脉腔静脉瘘失败。
Am J Physiol Heart Circ Physiol. 2025 Jun 1;328(6):H1147-H1167. doi: 10.1152/ajpheart.00661.2024. Epub 2025 Apr 17.
4
Negative regulation of lymphangiogenesis by Tenascin-C delays the resolution of inflammation.肌腱蛋白-C对淋巴管生成的负调控会延迟炎症的消退。
iScience. 2025 Jan 6;28(2):111756. doi: 10.1016/j.isci.2025.111756. eCollection 2025 Feb 21.
5
Comparative Proteomic Analysis of Endolymphatic Sac Luminal Fluid in Patients with Meniere's Disease and Controls.梅尼埃病患者与对照组内淋巴囊腔液的比较蛋白质组学分析
J Inflamm Res. 2024 Dec 4;17:10209-10222. doi: 10.2147/JIR.S474910. eCollection 2024.
6
IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors.IL-18R 支持的嵌合抗原受体 T 细胞针对癌胚 tenascin C 用于儿科肉瘤和脑肿瘤的免疫治疗。
J Immunother Cancer. 2024 Nov 20;12(11):e009743. doi: 10.1136/jitc-2024-009743.
7
Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome.Tenascin C 通过激活 toll 样受体 4/NF-κB 信号通路促进多囊卵巢综合征的发生。
Mol Med Rep. 2024 Jun;29(6). doi: 10.3892/mmr.2024.13230. Epub 2024 Apr 26.
8
Extracellular matrix complexity in biomarker studies: a novel assay detecting total serum tenascin-C reveals different distribution to isoform-specific assays.生物标志物研究中的细胞外基质复杂性:一种新型检测总血清腱糖蛋白 C 的检测方法显示与同工型特异性检测方法不同的分布。
Front Immunol. 2023 Nov 22;14:1275361. doi: 10.3389/fimmu.2023.1275361. eCollection 2023.
9
Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma.微环境成分在头颈部鳞状细胞癌中的作用
J Pers Med. 2023 Nov 17;13(11):1616. doi: 10.3390/jpm13111616.
10
Research progress of lens zonules.晶状体悬韧带的研究进展
Adv Ophthalmol Pract Res. 2023 Feb 25;3(2):80-85. doi: 10.1016/j.aopr.2023.02.002. eCollection 2023 May-Jun.

本文引用的文献

1
Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers.绘制 tenascin-C 与 toll 样受体 4 的相互作用图谱揭示了一组新的内源性炎症触发物。
Nat Commun. 2017 Nov 17;8(1):1595. doi: 10.1038/s41467-017-01718-7.
2
Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation.骨髓源性腱生蛋白-C通过控制炎症减轻心脏肥大。
J Am Coll Cardiol. 2017 Sep 26;70(13):1601-1615. doi: 10.1016/j.jacc.2017.07.789.
3
Regulation of Innate and Adaptive Immunity by TGFβ.转化生长因子β对固有免疫和适应性免疫的调节
Adv Immunol. 2017;134:137-233. doi: 10.1016/bs.ai.2017.01.001. Epub 2017 Feb 10.
4
CD73-derived adenosine and tenascin-C control cytokine production by epicardium-derived cells formed after myocardial infarction.CD73衍生的腺苷和肌腱蛋白-C控制心肌梗死后形成的心外膜衍生细胞的细胞因子产生。
FASEB J. 2017 Jul;31(7):3040-3053. doi: 10.1096/fj.201601307R. Epub 2017 Mar 31.
5
Effects of Tenascin-C Knockout on Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice.Tenascin-C 敲除对小鼠实验性蛛网膜下腔出血后脑血管痉挛的影响。
Mol Neurobiol. 2018 Mar;55(3):1951-1958. doi: 10.1007/s12035-017-0466-x. Epub 2017 Feb 27.
6
Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis.腱生蛋白-C缺乏可保护小鼠免受实验性自身免疫性脑脊髓炎的侵害。
J Neuroimmunol. 2017 Jan 15;302:1-6. doi: 10.1016/j.jneuroim.2016.12.001. Epub 2016 Dec 7.
7
Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis.早期滑膜炎患者中抗瓜氨酸化肌腱蛋白-C抗体的检测与类风湿关节炎的发生有关。
RMD Open. 2016 Dec 1;2(2):e000318. doi: 10.1136/rmdopen-2016-000318. eCollection 2016.
8
Tenascin-C at a glance.腱生蛋白-C简介。
J Cell Sci. 2016 Dec 1;129(23):4321-4327. doi: 10.1242/jcs.190546. Epub 2016 Nov 10.
9
Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease - A Multicenter Retrospective Study.血清腱生蛋白-C作为川崎病冠状动脉病变风险和静脉注射免疫球蛋白抵抗性的新型预测指标——一项多中心回顾性研究
Circ J. 2016 Oct 25;80(11):2376-2381. doi: 10.1253/circj.CJ-16-0563. Epub 2016 Oct 15.
10
Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation.炎症过程中Wnt/β-连环蛋白与核因子κB信号通路之间的相互作用
Front Immunol. 2016 Sep 22;7:378. doi: 10.3389/fimmu.2016.00378. eCollection 2016.

内政部:Tenascin-C 作为一种临床相关的内源性固有免疫驱动因素。

Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

机构信息

Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

出版信息

J Histochem Cytochem. 2018 Apr;66(4):289-304. doi: 10.1369/0022155418757443. Epub 2018 Jan 31.

DOI:10.1369/0022155418757443
PMID:29385356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5958381/
Abstract

To protect against danger, the innate immune system must promptly and accurately sense alarm signals, and mount an appropriate response to restore homeostasis. One endogenous trigger of immunity is tenascin-C, a large hexameric protein of the extracellular matrix. Upregulated upon tissue injury and cellular stress, tenascin-C is expressed during inflammation and tissue remodeling, where it influences cellular behavior by interacting with a multitude of molecular targets, including other matrix components, cell surface proteins, and growth factors. Here, we discuss how these interactions confer upon tenascin-C distinct immunomodulatory capabilities that make this matrix molecule necessary for efficient tissue repair. We also highlight in vivo studies that provide insight into the consequences of misregulated tenascin-C expression on inflammation and fibrosis during a wide range of inflammatory diseases. Finally, we examine how its unique expression pattern and inflammatory actions make tenascin-C a viable target for clinical exploitation in both diagnostic and therapeutic arenas.

摘要

为了防范危险,先天免疫系统必须迅速而准确地感知警报信号,并做出适当的反应以恢复体内平衡。一种内源性的免疫触发物是 tenascin-C,一种细胞外基质的大型六聚体蛋白。在组织损伤和细胞应激时上调,tenascin-C 在炎症和组织重塑期间表达,通过与多种分子靶标相互作用(包括其他基质成分、细胞表面蛋白和生长因子)影响细胞行为。在这里,我们讨论了这些相互作用如何赋予 tenascin-C 独特的免疫调节能力,使这种基质分子成为有效组织修复所必需的。我们还强调了体内研究,这些研究深入了解了在广泛的炎症性疾病中,tenascin-C 表达失调对炎症和纤维化的影响。最后,我们研究了其独特的表达模式和炎症作用如何使 tenascin-C 成为在诊断和治疗领域中具有临床应用潜力的可行靶标。